Sunday, Nov. 4, 2012 | LBCT.01: Practice Implications for CAD and VTE | 
Tim Brighton
Prince of Wales Hospital
Sydney, Australia
| Aspirin for The Prevention of Recurrent Venous Thromboembolism After a First Unprovoked Event: Results of the ASPIRE Randomized Controlled Trial | 
Gilles Montalescot
Pitié-Salpêtrière University Hospital
Paris, France | A Randomized Trial of Bedside Platelet Function Monitoring to Adjust Antiplatelet Therapy Versus Standard of Care in Patients Undergoing Drug Eluting Stent Implantation: The ARCTIC Study
| 
Paul A Gurbel
Sinai Hospital Center for Thrombosis Research
Baltimore, Md. | First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial - The TRILOGY ACS Platelet Function Sub-study
| 
Gervasio A Lamas
Mount Sinai Medical Center
Miami, Fla. | Results of the Trial to Assess Chelation Therapy
| 
Valentin Fuster
Mount Sinai School of Medicine
New York, N.Y. | Main Results of the Future REvascularization Evaluation in Patients with Diabetes Mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
|
|
Back to Top
|
| LBCT.02: Health Economics and Quality of Life in Contemporary Trials | 
Thomas R Porter
University of Nebraska Medical Center
Omaha, NE
| Prospective Evaluation of Outcomes With Stress Perfusion Imaging Versus Stress Wall Motion Imaging During Dobutamine or Exercise Echocardiography
| 
Eric L. Eisenstein
Duke Clinical Research Institute
Durham, NC | Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery
| 
Daniel B. Mark
Duke University Medical Center
Durham, NC | Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT)
|
Elizabeth A Magnuson
Saint Luke's Mid America Heart Institute
Kansas City, MO | Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial
|
|
Back to Top
|
Monday, Nov. 5, 2012 | LBCT.03: Treatments for Prevention of Cardiovascular Events: A Population Perspective | 
Alejandro Macchia
Consorzio Mario Negri Sud
Santa Maria Imb, Italy | Omega-3 fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: Results of a double-blind randomized clinical trial (FORWARD)
Presentation Slides | Summary Slide | Presentation Audio | Discussant Audio | 
Roberto Marchioli
Consorzio Mario Negri Sud
Santa Maria Imbaro, Italy | Fish Oil for the Prevention of Post-Operative Atrial Fibrillation - The Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial
Presentation Slides | Summary Slide | Presentation Audio | Discussant Audio |
Howard D Sesso
Brigham and Womens Hospital
Boston, MA | A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II
Presentation Slides | Summary Slide | Simon A Thom
Imperial Coll London
London, United Kingdom | Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE)
Summary Slide |
|
Back to Top
|
| LBCT.04: Novel Treatments for Managing Lipid Disorders | 
Jay Horton
Dallas, TX | Overview of PCSK9 Inhibition in the Treatment of Hyperlipidemia
Presentation Slides | 
Frederick Raal
Universotu of Witwatersrand Johannisburg
South Africa | Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Presentation Slides | Summary Slide | 
Evan Stein
Metabolic and Atherosclerosis Research Center Cincinnati, OH | Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects (GAUSS): Interim Results from a Randomized, Double-blind, Placebo-controlled Study
Summary Slide | 
Barry Gumbiner
Pfizer, Inc.
San Diego, CA | Effects of 12 Weeks of Treatment with RN316 (PF-04950615), a Humanized IgG2Δa Monoclonal Antibody Binding Proprotein Convertase Subtilisin Kexin Type 9, in Hypercholesterolemic Subjects on High and Maximal Dose Statins
Summary Slide | 
Gregory G Schwartz
VA Medical Center and University of Colorado
Denver, CO | Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome
Presentation Slides | Summary Slide |
|
Back to Top
|
|
|
| Tuesday, Nov. 6, 2012 |
Back to Top
|
| LBCT.06: Management of LV Dysfunction: Devices and Drugs | 
Arthur J. Moss
Univ of Rochester Medical Ctr, Rochester, NY | MADIT Randomized Trial to Reduce Inappropriate Therapy (MADIT-RIT)
Summary Slide | 
Anne B. Curtis
University at Buffalo
Buffalo, NY | Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block (BLOCK HF Study)
Presentation Slides | Summary Slide | 
Esteban Lopez-de-Sa
Hosp Univrio La Paz Madrid, Spain | Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Hospital Cardiac Arrest
Summary Slide | 
John R Teerlink
San Francisco VAMC UCSF
San Francisco, CA | The RELAXin in Acute Heart Failure (RELAX-AHF) Trial
Summary Slide | 
Bradley A Bart
Hennepin County Medical Center
Minneapolis, MN | Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network
Summary Slide |
|
Back to Top
|
| |
|
|
